Leederville-based medical dermatology company Botanix has received US Food and Drug Administration approval for its Sofdra gel, used to treat excessive underarms sweating.
The Australian Competition and Consumer Protection has voiced concerns over Sigma’s proposed acquisition of Chemist Warehouse, including potential barriers for other pharmacy retailers to expand.
Shares in Perth biotech company PharmAust rose by 14 per cent on Friday to 21 cents, following news Michael Thurn had been reappointed as the company’s managing director and chief executive officer.
Avita Medical shares have had a moderate rise after a US regulator approved the next reiteration of a regenerative cell system for burns developed by Perth surgeon Fiona Wood.
Michael Anghie-led APM Human Services International has entered a trading halt, pending an update regarding its non-binding acquisition proposal from US-based Madison Dearborn Partners.
Home care provider Silverchain has launched a philanthropic foundation to invest in new models of care, improve technology and increase access to health and aged care services.
Perth biotech company PYC Therapeutics has hit a major milestone in the development of a first-in-class drug to treat a rare eye disease, recently receiving orphan drug designation from the US FDA.
A health facility housing an MRI, medical imaging, GP and daycare backed by Broome dental clinic owner Stephanie Mulcahy has been earmarked for the Kimberley town.
The Telethon Kids institute was the big winner from the state government’s latest round of medical research funding, securing nearly half of the $25 million on offer.
A former public health employee found by the Corruption and Crime Commission to have siphoned more than $280,000 is facing 52 charges related to corruption.
A Joondalup-based medical cannabis producer is moving to capitalise on Germany’s recent decriminalisation of the drug, outlining plans to merge with one of Europe’s largest cannabis manufacturers.
Innovation hub Spacecubed has signed an MoU with one of India’s largest Medtech precincts, aimed at exploring collaborative opportunities for high-growth Medtech startups.
Shares in Claremont-based PharmAust rose 5 per cent early on Friday morning, following news the company had received orphan drug designation for both monepantel and the treatment of motor neurone disease and amyotrophic lateral sclerosis.
St John of God Health Care will stop operating maternity services at its Bunbury Hospital next month, citing a staff shortage in delivering private obstetric care in regional areas.
MSWA has broken ground on its long-awaited 24-hour care facility in Shenton Park, marking the start of a major project for the not-for-profit organisation.
Mental health services, including crisis support, will go virtual in a WA-first co-response model announced in a tranche of state government health budget commitments.
St John of God has proposed to build a five-storey private hospital in its Midland precinct, estimated to cost almost $160 million, to replace the services acquired by the state government.
Hesperia will start construction of a four-storey orthopaedic hospital, estimated to cost $69 million, by the end of the year after receiving unanimous support from a development panel.
A new co-ordinated emergency and medical care operations centre will be established in the old Telstra Exchange tower, to be operational by the end of the year.
Shares in Argenica Therapeutics were down by 13 per cent on Friday morning, despite the biotechnology technology announcing it would raise $12 million in order to complete its second phase trial of its ARG 007 drug in ischaemic stroke patients.
A joint venture between Multiplex Constructions and Perkins Builders has been contracted for main works of the Bunbury Regional Hospital's redevelopment project.
WA Liberal leader Libby Mettam has slammed the state government for inaction on potentially flammable cladding at Fiona Stanley Hospital identified five years ago.
The Child Development Service will go through an expansion and staff increase as part of a $39 million funding boost to ease “unprecedented” demand for the service.
